| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI |
NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc.("ICU" or the "Company") (NASDAQ:ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. |
accessnewswire.com |
2025-05-16 13:00:00 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI |
NEW YORK CITY, NY / ACCESS Newswire / May 14, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc.("ICU" or the "Company") (NASDAQ:ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. |
accessnewswire.com |
2025-05-14 13:00:00 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ICU Medical, Inc. – ICUI |
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. (“ICU” or the “Company”) (NASDAQ: ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. |
globenewswire.com |
2025-05-13 16:35:00 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI |
NEW YORK , May 12, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. ("ICU" or the "Company") (NASDAQ: ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. |
prnewswire.com |
2025-05-12 21:32:00 |
Czytaj oryginał (ang.) |
| ICU Medical, Inc. (ICUI) Q1 2025 Earnings Call Transcript |
ICU Medical, Inc. (NASDAQ:ICUI ) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants John Mills – ICR, IR Vivek Jain – Chief Executive Officer and Chairman Brian Bonnell – Chief Financial Officer Conference Call Participants Jayson Bedford – Raymond James Brett Fishbin – KeyBanc Capital Markets Larry Solow – CJS Securities Michael Toomey – Jefferies Operator Good day, and welcome to the ICU Medical, Inc. First Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note, today's event is being recorded. |
seekingalpha.com |
2025-05-10 16:13:22 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI |
NEW YORK CITY, NY / ACCESS Newswire / May 10, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc.("ICU" or the "Company") (NASDAQ:ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. |
accessnewswire.com |
2025-05-10 12:00:00 |
Czytaj oryginał (ang.) |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ICU Medical, Inc. (ICUI) And Encourages Shareholders to Reach Out |
NEW YORK CITY, NY / ACCESS Newswire / May 9, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. ("ICU Medical" or "the Company") (NASDAQ:ICUI). Investors who purchased ICU Medical securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ICUI. |
accessnewswire.com |
2025-05-09 14:00:00 |
Czytaj oryginał (ang.) |
| ICU Medical (ICUI) Q1 Earnings and Revenues Beat Estimates |
ICU Medical (ICUI) came out with quarterly earnings of $1.72 per share, beating the Zacks Consensus Estimate of $1.23 per share. This compares to earnings of $0.96 per share a year ago. |
zacks.com |
2025-05-08 23:50:29 |
Czytaj oryginał (ang.) |
| ICU Medical, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm |
BOSTON, MA / ACCESS Newswire / May 8, 2025 / Block & Leviton is investigating ICU Medical, Inc. (Nasdaq:ICUI) for potential securities law violations. Investors who have lost money in their ICU Medical, Inc. investment should contact the firm to learn more about how they might recover those losses. |
accessnewswire.com |
2025-05-08 21:30:00 |
Czytaj oryginał (ang.) |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ICU Medical, Inc. (ICUI) and Encourages Shareholders to Learn More About the Investigation |
NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. ("ICU Medical" or "the Company") (NASDAQ:ICUI). Investors who purchased ICU Medical securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ICUI. |
accessnewswire.com |
2025-05-08 14:00:00 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI |
NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc.("ICU" or the "Company") (NASDAQ:ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. |
accessnewswire.com |
2025-05-08 12:00:00 |
Czytaj oryginał (ang.) |
| ICU Medical, Inc. (ICUI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation |
NEW YORK CITY, NY / ACCESS Newswire / May 7, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. ("ICU Medical" or "the Company") (NASDAQ:ICUI). Investors who purchased ICU Medical securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ICUI. |
accessnewswire.com |
2025-05-07 14:00:00 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI |
NEW YORK CITY, NY / ACCESS Newswire / May 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc.("ICU" or the "Company") (NASDAQ:ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. |
accessnewswire.com |
2025-05-07 12:00:00 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI |
NEW YORK , May 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. ("ICU" or the "Company") (NASDAQ: ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. |
prnewswire.com |
2025-05-06 18:04:00 |
Czytaj oryginał (ang.) |
| Bronstein, Gewirtz & Grossman, LLC Encourages ICU Medical, Inc. (ICUI) Shareholders to Inquire about Securities Investigation |
NEW YORK CITY, NY / ACCESS Newswire / May 6, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. ("ICU Medical" or "the Company") (NASDAQ:ICUI). Investors who purchased ICU Medical securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ICUI. |
accessnewswire.com |
2025-05-06 14:00:00 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ICU Medical, Inc. – ICUI |
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. (“ICU” or the “Company”) (NASDAQ: ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. |
globenewswire.com |
2025-05-05 16:47:00 |
Czytaj oryginał (ang.) |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating ICU Medical, Inc. (ICUI) And Encourages Investors to Connect |
NEW YORK CITY, NY / ACCESS Newswire / May 5, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. ("ICU Medical" or "the Company") (NASDAQ:ICUI). Investors who purchased ICU Medical securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ICUI. |
accessnewswire.com |
2025-05-05 14:00:00 |
Czytaj oryginał (ang.) |
| Bronstein, Gewirtz & Grossman, LLC Encourages ICU Medical, Inc. (ICUI) Stockholders to Inquire about Securities Investigation |
NEW YORK CITY, NY / ACCESS Newswire / May 4, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. ("ICU Medical" or "the Company") (NASDAQ:ICUI). Investors who purchased ICU Medical securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ICUI. |
accessnewswire.com |
2025-05-04 14:00:00 |
Czytaj oryginał (ang.) |
| INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ICU Medical, Inc. - ICUI |
NEW YORK, NY / ACCESS Newswire / May 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of ICU Medical, Inc. ("ICU" or the "Company") (NASDAQ:ICUI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. |
accessnewswire.com |
2025-05-03 14:00:00 |
Czytaj oryginał (ang.) |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ICU Medical, Inc. (ICUI) and Encourages Investors to Learn More About the Investigation |
NEW YORK CITY, NY / ACCESS Newswire / May 2, 2025 / Attorney Advertising Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ICU Medical, Inc. ("ICU Medical" or "the Company") (NASDAQ:ICUI). Investors who purchased ICU Medical securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ICUI. |
accessnewswire.com |
2025-05-02 14:00:00 |
Czytaj oryginał (ang.) |
| ICU Medical to Present at the 43rd Annual J.P. Morgan Healthcare Conference |
SAN CLEMENTE, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 43rd Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 13-16, 2025. ICU Medical's presentation will be on Wednesday, January 15, 2025 at 10:30 a.m. PT (1:30 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, January 15, 2025 and Thursday, January 16, 2025. |
globenewswire.com |
2025-01-03 10:30:00 |
Czytaj oryginał (ang.) |
| ICU Medical Inc. (ICUI) Q3 2024 Earnings Call Transcript |
ICU Medical Inc. (NASDAQ:ICUI ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants John Mills - ICR Vivek Jain - Chief Executive Officer and Chairman Brian Bonnell - Chief Financial Officer Conference Call Participants Brett Fishbin - KeyBanc Eric Fleming - Raymond James Larry Solow - CJS Securities Kristen Stewart - CL King Mike Matson - Needham and Company Michael Toomey - Jefferies Operator Good day, everyone, and welcome to today's ICU Medical Inc.'s Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. |
seekingalpha.com |
2024-11-12 22:45:25 |
Czytaj oryginał (ang.) |
| ICU Medical (ICUI) Tops Q3 Earnings and Revenue Estimates |
ICU Medical (ICUI) came out with quarterly earnings of $1.59 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $1.57 per share a year ago. |
zacks.com |
2024-11-12 20:51:18 |
Czytaj oryginał (ang.) |
| ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc., a Subsidiary of Otsuka Holdings Co. Ltd., Announce Creation of a Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America |
The partnership creates one of the largest global IV solutions manufacturing networks with combined production of an estimated 1.4 billion annual units and aims to bring additional supply chain resiliency and new innovation to the North American IV solutions market. Joint venture becomes part of a global manufacturing network with scale and redundancy Intends to add long-term supply resiliency and accelerate IV solutions new product development in North America Combines Otsuka Pharmaceutical Factory, Inc.'s expertise and global manufacturing scale with ICU Medical's strong North American production and distribution ICU Medical to provide commercial services to the joint venture Expected to become operationally effective in early Q2 2025 Full presentation available for view here SAN CLEMENTE, Calif. |
prnewswire.com |
2024-11-12 18:05:00 |
Czytaj oryginał (ang.) |
| ICU Medical to Participate at the UBS Global Healthcare Conference |
SAN CLEMENTE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the UBS Global Healthcare Conference being held in Rancho Palos Verdes, California, November 11-14, 2024. ICU Medical's presentation will be on Wednesday, November 13, 2024 at 4:15 p.m. PT (7:15 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, November 13, 2024. |
globenewswire.com |
2024-11-06 10:30:00 |
Czytaj oryginał (ang.) |
| ICU Medical (ICUI) Expected to Beat Earnings Estimates: Should You Buy? |
ICU Medical (ICUI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2024-10-28 13:05:32 |
Czytaj oryginał (ang.) |
| ICU Medical Announces Time of Third Quarter 2024 Earnings Conference Call |
SAN CLEMENTE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2024 earnings release and conference call. |
globenewswire.com |
2024-10-28 10:30:00 |
Czytaj oryginał (ang.) |
| Will ICU Medical (ICUI) Beat Estimates Again in Its Next Earnings Report? |
ICU Medical (ICUI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. |
zacks.com |
2024-10-18 17:16:11 |
Czytaj oryginał (ang.) |
| ICU Medical's Stock Rises Despite Bivona Tracheostomy Tube Recall |
ICUI's Smiths Medical recalls Bivona tracheostomy tubes over a defect that may lead to serious health risks, including airway loss and death. |
zacks.com |
2024-09-25 15:45:19 |
Czytaj oryginał (ang.) |
| ICU Medical, Inc. (ICUI) Hits Fresh High: Is There Still Room to Run? |
ICU Medical (ICUI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. |
zacks.com |
2024-09-17 14:20:16 |
Czytaj oryginał (ang.) |
| ICU Medical, Inc. (ICUI) Hits Fresh High: Is There Still Room to Run? |
ICU Medical (ICUI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. |
zacks.com |
2024-08-23 14:17:07 |
Czytaj oryginał (ang.) |
| Is ICU Medical (ICUI) Stock Undervalued Right Now? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2024-08-22 14:46:32 |
Czytaj oryginał (ang.) |
| ICU Medical to Participate in Upcoming Investor Conferences |
SAN CLEMENTE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences in September: |
globenewswire.com |
2024-08-21 12:30:00 |
Czytaj oryginał (ang.) |
| ICU Medical Inc (ICUI) Q2 2024 Earnings Call Transcript |
ICU Medical Inc (NASDAQ:ICUI ) Q2 2024 Results Conference Call August 7, 2024 4:30 PM ET Company Participants John Mills - Managing Partner Vivek Jain - CEO & Chairman of the Board Brian Bonnell - CFO & Treasurer Conference Call Participants Larry Solow - CJS Securities Kristen Stewart - CL King Brett Fishbin - KeyBanc Capital Markets Mike Matson - Needham & Company Jayson Bedford - Raymond James Operator Good afternoon, ladies and gentlemen, and welcome to the ICU Medical Inc Second Quarter 2024 Earnings Conference Call. At this time, all lines are in a listen-only mode. |
seekingalpha.com |
2024-08-08 00:00:08 |
Czytaj oryginał (ang.) |
| ICU Medical (ICUI) Surpasses Q2 Earnings and Revenue Estimates |
ICU Medical (ICUI) came out with quarterly earnings of $1.56 per share, beating the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $1.88 per share a year ago. |
zacks.com |
2024-08-07 23:15:19 |
Czytaj oryginał (ang.) |
| Swiss National Bank Lowers Stock Position in ICU Medical, Inc. (NASDAQ:ICUI) |
Swiss National Bank decreased its holdings in ICU Medical, Inc. (NASDAQ:ICUI – Free Report) by 10.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 40,419 shares of the medical instruments supplier’s stock after selling 4,600 shares during the quarter. Swiss National Bank owned about 0.17% of ICU Medical worth $4,031,000 at the end of the most recent quarter. A number of other large investors have also recently bought and sold shares of ICUI. WCM Investment Management LLC boosted its stake in shares of ICU Medical by 37.5% during the fourth quarter. WCM Investment Management LLC now owns 242,808 shares of the medical instruments supplier’s stock worth $24,223,000 after buying an additional 66,221 shares during the period. State of Alaska Department of Revenue grew its stake in shares of ICU Medical by 417.8% in the 4th quarter. State of Alaska Department of Revenue now owns 12,475 shares of the medical instruments supplier’s stock valued at $1,244,000 after purchasing an additional 10,066 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of ICU Medical by 7.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 168,957 shares of the medical instruments supplier’s stock valued at $20,108,000 after purchasing an additional 11,364 shares during the period. Louisiana State Employees Retirement System acquired a new position in shares of ICU Medical in the fourth quarter valued at approximately $1,007,000. Finally, Federated Hermes Inc. raised its stake in shares of ICU Medical by 6.5% during the third quarter. Federated Hermes Inc. now owns 125,967 shares of the medical instruments supplier’s stock worth $14,991,000 after purchasing an additional 7,675 shares during the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock. Wall Street Analyst Weigh In Separately, KeyCorp boosted their price objective on shares of ICU Medical from $134.00 to $136.00 and gave the company an “overweight” rating in a research note on Wednesday, February 28th. Check Out Our Latest Report on ICU Medical Insider Activity at ICU Medical In other ICU Medical news, Director Elisha W. Finney sold 300 shares of the company’s stock in a transaction dated Thursday, May 16th. The shares were sold at an average price of $104.95, for a total transaction of $31,485.00. Following the transaction, the director now directly owns 2,129 shares in the company, valued at $223,438.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other ICU Medical news, COO Christian B. Voigtlander sold 13,603 shares of the business’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $107.19, for a total transaction of $1,458,105.57. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Elisha W. Finney sold 300 shares of the firm’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $104.95, for a total value of $31,485.00. Following the completion of the transaction, the director now owns 2,129 shares of the company’s stock, valued at approximately $223,438.55. The disclosure for this sale can be found here. Insiders sold 26,562 shares of company stock worth $2,788,117 over the last 90 days. Company insiders own 6.70% of the company’s stock. ICU Medical Stock Performance NASDAQ ICUI opened at $103.99 on Monday. The stock has a market capitalization of $2.53 billion, a price-to-earnings ratio of -42.44 and a beta of 0.72. The business’s 50 day moving average is $100.63 and its two-hundred day moving average is $97.29. ICU Medical, Inc. has a 12-month low of $78.28 and a 12-month high of $196.57. The company has a current ratio of 2.61, a quick ratio of 1.09 and a debt-to-equity ratio of 0.76. ICU Medical (NASDAQ:ICUI – Get Free Report) last announced its quarterly earnings data on Tuesday, February 27th. The medical instruments supplier reported $1.24 earnings per share for the quarter, topping analysts’ consensus estimates of $0.85 by $0.39. ICU Medical had a positive return on equity of 5.38% and a negative net margin of 2.63%. The firm had revenue of $587.86 million for the quarter, compared to analyst estimates of $564.77 million. Research analysts expect that ICU Medical, Inc. will post 3.53 EPS for the current year. ICU Medical Company Profile (Free Report) ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. |
https://www.defenseworld.net |
2024-05-20 08:42:50 |
Czytaj oryginał (ang.) |
| ICU Medical, Inc. (ICUI) Q1 2024 Earnings Call Transcript |
ICU Medical, Inc. (NASDAQ:ICUI ) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants John Mills - Managing Partner at ICR Vivek Jain - Chief Executive Officer & Chairman Brian Bonnell - Chief Financial Officer Conference Call Participants Jayson Bedford - Raymond James Brett Fishbin - KeyBanc Kristen Stewart - CL King Larry Solow - CJS Securities Operator Good afternoon, ladies and gentlemen and welcome to the ICU Medical Incorporated. First Quarter 2024 Earnings Conference Call. |
seekingalpha.com |
2024-05-08 02:43:09 |
Czytaj oryginał (ang.) |
| ICU Medical (ICUI) Q1 Earnings and Revenues Surpass Estimates |
ICU Medical (ICUI) came out with quarterly earnings of $0.96 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $1.74 per share a year ago. |
zacks.com |
2024-05-07 22:56:13 |
Czytaj oryginał (ang.) |
| ICU Medical Announces First Quarter 2024 Results |
SAN CLEMENTE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2024. |
globenewswire.com |
2024-05-07 20:05:00 |
Czytaj oryginał (ang.) |
| ICU Medical Announces Time of First Quarter 2024 Earnings Conference Call |
SAN CLEMENTE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2024 earnings release and conference call. |
globenewswire.com |
2024-04-23 12:30:00 |
Czytaj oryginał (ang.) |